At present, the main methods of T2DM drug treatment are subcutaneous insulin injection and oral hypoglycemic drugs (such as double pulse, sulfonyl artery, and a glyoxylase inhibitors); but with the development of the diseas. The gene discussed is INS; the disease is type 2 diabetes mellitus.